Startup Originals Team
Bengaluru-based skincare startup Asaya has raised ₹88 crore in a Series A funding round at a valuation of ₹400 crore, as the science-led brand looks to expand its product portfolio and distribution network across India.
The round saw participation from RPSG Capital, OTP Ventures, Huddle Ventures, Hyperscale Ventures and 72 Ventures, along with prominent investors associated with these firms. The funding comes as Asaya scales its focus on skincare designed specifically for melanin-rich skin, with hyperpigmentation at the centre of its product strategy.
The company said it is currently operating at a ₹100 crore annual recurring revenue (ARR) run rate. It is targeting ₹200 crore in ARR within the next 18 months, while also increasing investment in research and development.
What Happened?
Asaya has secured ₹88 crore in Series A funding at a ₹400 crore valuation. The Bengaluru-based startup plans to use the capital to strengthen its science and product development capabilities while expanding its reach across online and offline channels.
Around one-fifth of the fresh capital will be allocated to R&D, according to co-founder Neeraj Biyani. The remaining funds will be directed towards expanding the company’s product range as well as geographic and distribution channels.
The latest investment gives Asaya additional capital at a time when India’s skincare market is seeing increased interest in specialised, ingredient-focused and science-led brands.
The company said it has reached a ₹100 crore ARR run rate and is targeting ₹200 crore within 18 months. Biyani said the company is now variable-contribution profitable and plans to maintain its focus on sustainable growth.
Key Details
The funding round brought together a group of investors from the Indian startup and consumer ecosystem.
Participants include RPSG Capital, represented by Abhishek Goenka and Sambit Dash; OTP Ventures, represented by Suhail Sameer, Kunal Suri and Saurabh Vashishtha; Huddle Ventures, represented by Ishaan Khosla and Sanil Sachar; Hyperscale Ventures, represented by Suyash Saraf and Anisha Saraf; and 72 Ventures, represented by Sanjay Nayar and Falguni Nayar.
Asaya’s product portfolio is built around hyperpigmentation and skincare needs associated with melanin-rich skin. Its range includes cleansers, serums, spot treatments, moisturisers and sunscreens, giving customers products across different stages of a skincare routine.
One of its key technologies is MelaMe, a proprietary, patent-pending complex developed by the company. Asaya says the technology has been clinically tested and is designed to deliver visible improvement in hyperpigmentation in 14 days.
The company has spent more than two years developing MelaMe and has positioned the technology as a core differentiator for its product range.
Why This Matters
The Asaya funding highlights the growing investor interest in specialised skincare brands that combine direct-to-consumer distribution with proprietary product development.
Instead of competing across a broad range of beauty categories, Asaya has built its positioning around melanin-rich skin and hyperpigmentation. This gives the company a narrower product focus while allowing it to invest more deeply in research around a specific consumer need.
The company’s decision to allocate nearly 20% of the latest funding to R&D also signals its intention to build product differentiation through formulation and clinical research rather than relying only on marketing.
For the wider Indian beauty industry, the development reflects a shift towards brands that target specific skin concerns and consumer groups with specialised formulations.
Company Background
Asaya was founded in 2021 by Neeraj Biyani, Eeti Sharma and Mandeep Singh Bhatia. The Bengaluru-based startup operates as a D2C skincare brand focused on products for hyperpigmentation and other skin concerns.
The company has developed a portfolio spanning cleansers, serums, creams, spot treatments and sunscreens. Its core proposition is built around science-backed skincare for melanin-rich skin.
MelaMe is central to this strategy. Asaya describes it as a proprietary technology developed specifically to address pigmentation and uneven skin tone. The company has continued to invest in research around the technology and plans to develop additional proprietary solutions.
The startup has also recorded strong customer growth. Industry reporting in July 2026 said Asaya had crossed 5 lakh customers after recording fivefold revenue growth over the previous year.
Distribution And Market Expansion
Asaya is now looking beyond its own website to reach more customers.
The company is expanding its distribution through quick-commerce platforms and is exploring partnerships with offline retailers. Its online serviceable network has grown to more than 18,000 PIN codes, while more than 2,000 PIN codes can receive deliveries within 24 hours.
The move towards quick commerce is particularly relevant for skincare brands because consumers increasingly expect faster delivery for frequently purchased personal-care products.
Offline expansion could give Asaya another route to reach customers who prefer to discover and purchase skincare products in physical stores.
Industry Impact
India’s beauty and personal-care market has seen the emergence of several D2C brands focused on ingredient-led and science-backed products. Investors have also continued to fund specialised skincare companies as consumers become more aware of formulations and specific skin concerns.
Asaya’s approach adds another layer to this competition by focusing specifically on melanin-rich skin and hyperpigmentation.
The emphasis on proprietary technology could also influence how emerging skincare companies compete. As brands move beyond basic product claims, investment in clinical testing, research and differentiated formulations is becoming increasingly important.
For consumers, greater competition in specialised skincare could lead to more products designed around specific concerns rather than generic beauty positioning.
Future Plans
Asaya plans to use the latest funding across R&D, product-line expansion and geographic and channel growth.
The company expects to direct almost one-fifth of the ₹88 crore round towards research and development. It also plans to continue developing proprietary skincare technologies, with the company indicating that a second proprietary solution is under development.
Distribution will remain another major focus. Asaya is expanding through quick-commerce channels and evaluating offline retail partnerships to increase its reach.
With a current ARR run rate of ₹100 crore, the startup has set a target of reaching ₹200 crore ARR within 18 months. Achieving that target will depend on its ability to scale distribution while maintaining product performance and profitability.
Conclusion
The Asaya funding of ₹88 crore at a ₹400 crore valuation marks an important step for the Bengaluru-based skincare startup as it seeks to build a larger science-led beauty business.
With ₹100 crore in ARR, more than five lakh customers and a growing portfolio centred on melanin-rich skin, Asaya is using the new capital to strengthen R&D, launch more products and expand its distribution network.
Its focus on proprietary technology such as MelaMe and specialised skincare gives the company a distinct position in India’s competitive beauty market. The next phase will centre on converting that product differentiation into wider distribution and the company’s ₹200 crore ARR target.
